Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Survival outcomes of adolescents and young adults with lymphoblastic lymphoma treated with pediatric-inspired protocols in the Middle East

View Full Paper
Ask AI
Bookmark
Share

Authors

YBYazeed BajuaiferKing Faisal Specialist Hospital & Research Centre

Discussion

Loading...

Member takes

Overview

Retrospective analysis reports 70% survival in adolescents and young adults with lymphoblastic lymphoma, indicating pediatric protocols are effective.

Key Points

  • Overall survival for patients with lymphoblastic lymphoma was 65.5%, showing promising results with pediatric-inspired protocols.
  • Progression-free survival reached 70.2%, and 70% of adolescents and young adults were alive at last follow-up.
  • Retrospective analysis from King Faisal Specialist Hospital assessed clinical features, treatment-related toxicities, and survival.
  • Hematopoietic stem cell transplantation showed early post-transplant survival, but larger studies are needed for validation.

Cite This Study

Yazeed Bajuaifer (2025) studied this question.

synapsesocial.com/papers/69362f694fa91c937236decehttps://doi.org/10.1182/blood-2025-6846
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical characteristics and treatment evaluation of T-cell lymphoblastic lymphoma in Chinese children and adolescents：a multicenter clinical study of China-net childhood lymphoma-lbl-20172025
  2. 2Overall survival in patients with acute lymphoblastic leukemia in the aya population, treated with modified pediatric chemotherapeutic schemes, a real-life study2025
  3. 3T-cell acute lymphoblastic leukemia: therapeutic outcomes in adolescents and young adults2025 · 2 citations
  4. 4Comparative prognosis of pediatric lymphoblastic lymphoma: insights from Chinese and international cohorts2025
  5. 5Real-world data of adolescents and young adults with acute lymphoblastic leukemia treated with a modified GMALL protocol in India: Treatment outcomes and challenges2025